31.07.2013 23:40:00

U.S. Renal Care, Inc. -- Correction to Text, July 24, 2013 Release: Moody's rates U.S. Renal's 1st and 2nd lien term loan add-ons Ba3 and B3, respectively: outlook changed to negative and B2 CFR...

New York, July 31, 2013 -- In the debt list, corrected maturity date for the rating assigned to the $160 million second lien term loan from 2012 to 2020.

Vollständigen Artikel bei Moodys lesen